Open Access Pub publishes peer-reviewed, free-to-read open-access articles. Showing
articles matching Dolutegravir — open any to read the full text,
or download the PDF or XML.
Dolutegravir suppresses this integration enzyme, so human immune virus can’t create every greater copies of itself, thus ‘’integrase inhibitor.’’ Dolutegravir is hastily absorbed pursuing oral administration. The median maximum plasma concentration is reached 1.5–2.5 hours after oral uptake with a m…
Mar 2026 DOI 10.14302/issn.2994-6743.ijstd-26-6060
Pier Francesco AmadeoCorresponding author
Objective To describe the clinical features and real-world treatment of people living with human immunodeficiency virus (PLHIV) using fixed-dose or free combinations of 2-drug regimens (2DR) of antiretroviral therapy (ART). Design Italian retrospective cohort study. Methods Data were extracted from…